News
05.04.2022
Dao Tun advised Quimatryx in a 92 million dollars licensing deal for a cancer drug
22.03.2022
Dao Tun forms strategic partnership with Viopas Venture Consulting
31.01.2022
Dao Tun GmbH welcomes Dr. Ulf Grawunder as new Advisor to the Team
04.12.2018
Dao Tun CEO Tianke Wang interviewed in industry publication "Labiotech.eu"